Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells.

Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells.

Somatostatin analogues (SSA) represent the standard of care for symptom control in patients with functional gastro-entero-pancreatic neuroendocrine tumors (GEP-NET). In addition, SSA exert significant anti-proliferative effects in mid-gut and pancreatic NET (PanNET). In parallel, molecularly targete...

Full description

Bibliographic Details
Main Authors: Sebastian Krug, Jan-Philipp Mordhorst, Fabian Moser, Katharina Theuerkorn, Claudia Ruffert, Maren Egidi, Anja Rinke, Thomas M Gress, Patrick Michl
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0218953

Internet

https://doi.org/10.1371/journal.pone.0218953

Similar Items